CDER Dispute Resolution Process Gained Prominence In 2007

FDA's formal dispute resolution process had a higher profile in 2007 than previous years, suggesting that the rising number of multiple action letters and increasingly vocal criticism of FDA intransigence likely have contributed to the trend of more - or more public - formal appeals